发明授权
- 专利标题： Lactamimides as calcium antagonists
- 专利标题（中）： 内酰胺酰胺作为钙拮抗剂
-
申请号： US620226申请日： 1990-11-29
-
公开(公告)号： US5082837A公开(公告)日： 1992-01-21
- 发明人: Michael G. Palfreyman , Norbert L. Wiech , Hsien C. Cheng , John M. Kane
- 申请人： Michael G. Palfreyman , Norbert L. Wiech , Hsien C. Cheng , John M. Kane
- 申请人地址： OH Cincinnati
- 专利权人： Merrell Dow Pharmaceuticals
- 当前专利权人： Merrell Dow Pharmaceuticals
- 当前专利权人地址： OH Cincinnati
- 主分类号： A61K31/395
- IPC分类号： A61K31/395 ; A61K31/40 ; A61K31/445 ; A61K31/55
摘要：
Applicants have discovered that certain previously known lactamimide derivatives possess, as a class, valuable calcium channel blocking activity. By virtue of this calcium antagonism activity the compounds are antihypertensives and will have other activites associated with calcium antagonists.
公开/授权文献
信息查询
